Skip to Main Content (Press Enter)

Logo UNISS
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Professioni
  • Persone
  • Pubblicazioni
  • Strutture
  • Terza Missione
  • Competenze

Logo UNISS

|

UNIFIND

uniss.it
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Professioni
  • Persone
  • Pubblicazioni
  • Strutture
  • Terza Missione
  • Competenze
  1. Pubblicazioni

ANTIVIRAL THERAPY

Rivista
Codice:
E012519
ISSN:
1359-6535
  • Dati Generali

Dati Generali

Pubblicazioni (14)

  • ascendente
  • decrescente
Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome
Articolo
Bone mass loss risk in HIV-infected patients treated with highly active antiretroviral therapy including protease inhibitors
Abstract
Bone mineral mass loss risk in HIV-infected patients on HAART: a longitudinal study
Abstract
Cytopenias during treatment of HIV-HCV-coinfection with pegylated interferon and ribavirin: safety analysis of the OPERA study.
Articolo
Distinct hepatitis C virus kinetics in HIV-infected patients treated with ribavirin plus either pegylated interferon alpha2a or alpha2b
Articolo
Hepatitis C virus-RNAclearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin
Articolo
Long-term follow-up of HIV-infected patients with chronic hepatitis C virus infection treated with interferon-based therapies
Articolo
Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C treated with abacavir
Articolo
OPERA: use of pegylated interferon plus ribavirin for treating hepatitis C/HIV co-infection in interferon-naive patients.
Articolo
Overestimation of liver fibrosis staging using transient elastography in patients with chronic hepatitis C and significant liver inflammation
Articolo
Triple combination therapy for hepatitis C with telaprevir exhibits greater early antiviral activity than with boceprevir.
Articolo
Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation?
Articolo
Very late HCV relapse following triple therapy for hepatitis C.
Articolo
Visceral Leishmaniasis and Pegylated Interferon. Author’s reply
Articolo
No Results Found
  • «
  • ‹
  • {pageNumber}
  • ›
  • »
{startItem} - {endItem} di {itemsNumber}
  • Utilizzo dei cookie

Realizzato con VIVO | Designed by Cineca | 26.5.1.0